By using this site, you agree to the Privacy Policy and Terms of Use.
Accept

Amed Post

Breaking News,magazine, sport, life

Notification Show More
Font ResizerAa
Reading: Urgent recall issued for common blood pressure tablets
Share
Font ResizerAa

Amed Post

Breaking News,magazine, sport, life

Search
Have an existing account? Sign In
Follow US
Health

Urgent recall issued for common blood pressure tablets

amedpost
Last updated: November 5, 2026 11:14 am
amedpost
Published: November 5, 2026
Share
SHARE


Thousands of Brits taking commonly prescribed blood pressure medications have been issued an urgent warning after several products were recalled. A batch of Lercanidipine Hydrochloride 10mg tablets has been recalled by Accord-UK Ltd after a packaging mistake resulted in tablets of the wrong strength being placed in some packs.

The medication is widely prescribed across the UK to help control high blood pressure, also known as hypertension, by relaxing and widening blood vessels, making it easier for blood to flow around the body.

Hundreds of thousands of people rely on the treatment each year to manage the condition and reduce the risk of serious health problems such as heart attacks and strokes.

A complaint submitted to the Medicines and Healthcare products Regulatory Agency (MHRA) revealed that one affected pack contained a strip of the correct 10mg tablets alongside a strip of 20mg tablets, raising concerns about patients receiving the wrong dose.

Health officials warned that if someone prescribed a 10mg daily dose were to take 20mg tablets instead for a two-week period, they could experience an increased pharmacological effect from the medication.

This may result in a greater-than-expected drop in blood pressure, potentially causing symptoms such as dizziness, headaches, flushing, heart palpitations and symptomatic hypotension.

The recall is currently being carried out at pharmacy and wholesaler level, as health officials have assessed the overall risk to patients as low.

Authorities said this is because the 20mg tablets remain within the approved dosing range for the medication, the two strengths can be distinguished by their different colours, and reports of the packaging defect are believed to be extremely limited.

Patients who have been prescribed Lercanidipine Hydrochloride 10mg and have received packs from batch number M2510877 are being advised to inspect the blister strips carefully to ensure the tablets match their prescribed dosage.

Patients who find only blister strips labelled Lercanidipine Hydrochloride 10mg inside their pack do not need to take any further action.

However, anyone who discovers blister strips marked as 20mg is being advised not to take the medication and to contact their pharmacist for guidance.

People who experience symptoms such as dizziness, headaches, flushing or heart palpitations should seek medical attention without delay.

Any suspected side effects or adverse reactions can also be reported through the MHRA Yellow Card Scheme, which monitors the safety of medicines across the UK.

Places you’re most likely to die before 60 revealed – check your area
DIY facial massage technique may clear your sinuses at home
I’m a GP — here are five natural ways to help lower blood pressure
Time to fix palliative care – charities call for £200m in Budget
How to spot fake cosmetic products that may contain mercury and lead

Subscribe

Subscribe to our newsletter to get our newest articles instantly!

[mc4wp_form]

Share This Article
Facebook Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

© AMED POST Design Company. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?